Human Molecular Genetic and Functional Studies Identify TRIM63, Encoding Muscle RING Finger Protein 1, as a Novel Gene for Human Hypertrophic Cardiomyopathy
暂无分享,去创建一个
Raffaella Lombardi | A. Marian | Jianping Jin | J. Willerson | G. Czernuszewicz | Jianping Jin | James T Willerson | Ali J Marian | R. Lombardi | Yanli Tan | Suet Nee Chen | Grazyna Czernuszewicz | Yanli Tan | S. Chen
[1] 杜昕,et al. Inherited cardiomyopathies , 2012 .
[2] Joseph K. Pickrell,et al. A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes , 2012, Science.
[3] A. Marian,et al. Nuclear Plakoglobin Is Essential for Differentiation of Cardiac Progenitor Cells to Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy , 2011, Circulation research.
[4] H. Watkins,et al. Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy. , 2011, Circulation research.
[5] L. Carrier,et al. The ubiquitin–proteasome system in cardiomyopathies , 2011, Current opinion in cardiology.
[6] R. Austin,et al. Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease: endoplasmic reticulum stress as a mediator of pathogenesis. , 2011, Circulation research.
[7] A. Marian. Hypertrophic cardiomyopathy: from genetics to treatment , 2010, European journal of clinical investigation.
[8] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[9] Thomas Eschenhagen,et al. The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy. , 2010, Cardiovascular Research.
[10] S. Lecker,et al. Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms. , 2010, Cardiovascular research.
[11] R. Reimer,et al. Nonsense-Mediated mRNA Decay and Ubiquitin–Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic Mice , 2009, Circulation research.
[12] J. Schisler,et al. Cardiac Muscle Ring Finger-1 Increases Susceptibility to Heart Failure In Vivo , 2009, Circulation research.
[13] S. Gygi,et al. During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation , 2009, The Journal of cell biology.
[14] R. Schwartz,et al. Genetic Fate Mapping Identifies Second Heart Field Progenitor Cells As a Source of Adipocytes in Arrhythmogenic Right Ventricular Cardiomyopathy , 2009, Circulation research.
[15] I. Hisatome,et al. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy. , 2008, Journal of molecular biology.
[16] M. Willis,et al. The ubiquitin-proteasome system in cardiac dysfunction. , 2008, Biochimica et biophysica acta.
[17] O. Mayans,et al. Structural analysis of B-Box 2 from MuRF1: identification of a novel self-association pattern in a RING-like fold. , 2008, Biochemistry.
[18] Il-Jin Kim,et al. FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression , 2008, Science.
[19] A. Marian,et al. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies. , 2008, Cardiovascular research.
[20] A. Marian. Genetic determinants of cardiac hypertrophy , 2008, Current opinion in cardiology.
[21] V. Rybin,et al. Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis. , 2008, Journal of molecular biology.
[22] S. Rakhilin,et al. The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle. , 2007, Cell metabolism.
[23] Sanjay Shete,et al. Genome-wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy. , 2007, Human molecular genetics.
[24] Mi-Sung Kim,et al. Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3. , 2007, The Journal of clinical investigation.
[25] H. Worman,et al. "Laminopathies": a wide spectrum of human diseases. , 2007, Experimental cell research.
[26] S. Shete,et al. Myozenin 2 Is a Novel Gene for Human Hypertrophic Cardiomyopathy , 2007, Circulation research.
[27] Cam Patterson,et al. Muscle Ring Finger 1, but not Muscle Ring Finger 2, Regulates Cardiac Hypertrophy In Vivo , 2007, Circulation research.
[28] C. Patterson,et al. Into the heart: the emerging role of the ubiquitin-proteasome system. , 2006, Journal of molecular and cellular cardiology.
[29] J. Molkentin,et al. Regulation of cardiac hypertrophy by intracellular signalling pathways , 2006, Nature Reviews Molecular Cell Biology.
[30] A. Marian,et al. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation. , 2006, Journal of the American College of Cardiology.
[31] J. Robbins,et al. Regulation of Transgene Expression Using Tetracycline , 2005, Current protocols in molecular biology.
[32] Holly McDonough,et al. Muscle ring finger protein-1 inhibits PKCε activation and prevents cardiomyocyte hypertrophy , 2004, The Journal of cell biology.
[33] Cam Patterson,et al. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] Da-Zhi Wang,et al. Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex. , 2004, The Journal of clinical investigation.
[35] Q. Liang,et al. Reengineering Inducible Cardiac-Specific Transgenesis With an Attenuated Myosin Heavy Chain Promoter , 2003, Circulation research.
[36] Iacopo Olivotto,et al. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. , 2003, Journal of the American College of Cardiology.
[37] M. Hochstrasser,et al. Analysis of Protein Ubiquitination , 2002, Current protocols in protein science.
[38] C. Gregorio,et al. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1 , 2002, The Journal of cell biology.
[39] A. Goldberg,et al. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[40] D J Glass,et al. Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy , 2001, Science.
[41] K. Pelin,et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. , 2001, Journal of molecular biology.
[42] P. Elliott,et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.
[43] E. Lakatta,et al. Erratum: Culture and adenoviral infection of adult mouse cardiac myocytes: Methods for cellular genetic physiology (American Journal of Physiology - Heart and Circulatory Physiology (July 2000) 279:48 (H429-H436)) , 2000 .
[44] A. Weissman,et al. RING Finger Proteins Mediators of Ubiquitin Ligase Activity , 2000, Cell.
[45] E. Lakatta,et al. Culture and adenoviral infection of adult mouse cardiac myocytes: methods for cellular genetic physiology. , 2000, American journal of physiology. Heart and circulatory physiology.
[46] B. Maron,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[47] A. Marian,et al. Expression of a mutant (Arg92Gln) human cardiac troponin T, known to cause hypertrophic cardiomyopathy, impairs adult cardiac myocyte contractility. , 1997, Circulation research.
[48] D. Mann,et al. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. , 1995, Circulation research.
[49] P. Simpson,et al. Stimulation of hypertrophy of cultured neonatal rat heart cells through an alpha 1-adrenergic receptor and induction of beating through an alpha 1- and beta 1-adrenergic receptor interaction. Evidence for independent regulation of growth and beating. , 1985, Circulation research.
[50] H. Watkins,et al. Inherited cardiomyopathies. , 2011, The New England journal of medicine.
[51] R. Shephard. Sudden Deaths in Young Competitive Athletes: Analysis of 1866 Deaths in the United States, 1980–2006 , 2010 .